Overview

  • Product name
    Anti-Influenza B Virus antibody (HRP)
    See all Influenza B Virus primary antibodies
  • Description
    Goat polyclonal to Influenza B Virus (HRP)
  • Host species
    Goat
  • Conjugation
    HRP
  • Tested applications
    Suitable for: ELISA, WBmore details
  • Immunogen

    Yamagata strain of Influenza B

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Store at +4°C.
  • Storage buffer
    Preservative: 0.002% Thimerosal (merthiolate)
    Constituents: PBS, 1% BSA
  • Concentration information loading...
  • Purity
    IgG fraction
  • Purification notes
    Purified IgG fraction of antiserum covalently coupled to a highly purified preparation of Horseradish Peroxidase (RZ>3). Care is taken to ensure adequate conjugation while preserving maximum enzyme activity. Free enzyme is removed. Estimated molar HRP: IgG substitution is 2-3.
  • Clonality
    Polyclonal
  • Isotype
    IgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab20039 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA
WB
  • Application notes
    ELISA: 1/200 - 1/1000.
    WB: 1/20 - 1/200. Dilution optimised using Chromogenic detection.

    Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Relevance
      Influenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza B viruses currently circulating are divided into two antigenically and genetically distinct groups: the Victoria and Yamagata lineages.
    • Cellular localization
      Nuclear
    • Alternative names
      • NP antibody
      • Nucleocapsid protein antibody
      • Nucleoprotein antibody
      • Protein N antibody

    References

    This product has been referenced in:
    • Leung DYM  et al. A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis. J Allergy Clin Immunol 139:1575-1582.e8 (2017). Read more (PubMed: 28209343) »
    See 1 Publication for this product

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab20039.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up